Across the U.S. and internationally, individuals who used GLP-1 medications — including Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Saxenda, Victoza, and Zepbound — are reporting serious gastrointestinal, pancreatic, kidney, and gallbladder complications. Many are filing legal claims alleging that manufacturers did not adequately warn patients about the risk of severe or permanent injuries.
This central hub explains the core legal issues in developing GLP-1 litigation, the medical complications most frequently reported, who may qualify, and how claim evaluation works.
What Are GLP-1 Drug Lawsuits About?
Many lawsuits allege that manufacturers:
- downplayed or failed to properly warn about severe GI motility risks
- did not adequately disclose potential for gastroparesis (stomach paralysis)
- minimized risks of pancreatitis, kidney injury, gallbladder disease, and bowel obstruction
- expanded marketing into weight-loss categories without complete long-term safety data
- presented GLP-1 drugs as low-risk despite post-market injury reports
At the center of these claims are injuries that frequently require emergency care, hospitalization, surgery, long-term treatment, and lifestyle modification.
Injuries Commonly Reported in Claims
Many cases involve one or more of the following:
Gastroparesis (Stomach Paralysis)
Patients report:
- chronic vomiting
- inability to digest food
- long-term gastric dysfunction
- months or years of motility impairment
Pancreatitis
Cases include:
- hospitalization
- recurring inflammation
- severe abdominal pain
- post-episode pancreatic dysfunction
Kidney Injury & Kidney Failure
Often linked to dehydration from severe vomiting or pancreatitis complications.
Gallbladder Disease & Removal
Reports include:
- gallstones
- inflamed gallbladder
- bile duct obstruction
- emergency or surgical removal
Intestinal Obstruction & Severe Motility Disorders
Some claims describe:
- total GI shutdown
- blocked intestines
- feeding tube placement
- extreme abdominal swelling
➡️ Intestinal Obstruction Claims
Chronic Vomiting, Dehydration & Organ Stress
This category includes long-term injury caused by:
- prolonged fluid loss
- electrolyte imbalance
- repeated ER visits
- kidney decline
➡️ Dehydration & Kidney Damage Claims
Drugs Involved in Lawsuits
Legal actions have been reported against manufacturers of:
Each drug now has dedicated claim pages:
➡️ Ozempic Lawsuits
➡️ Wegovy Lawsuits
➡️ Mounjaro Lawsuits
➡️ Rybelsus Lawsuits
➡️ Saxenda Lawsuits
➡️ Trulicity Lawsuits
➡️ Victoza Lawsuits
➡️ Zepbound Lawsuits
What Legal Claims Typically Allege
Claim language varies by case, but many lawsuits include allegations that:
- drug warnings were incomplete
- patients were not properly informed of severe GI motility risks
- the safety profile was unclear due to limited long-term trials
- post-market injury signals were not sufficiently communicated
- injury risks were downplayed even as prescriptions expanded beyond diabetes use
Some claims also assert that “minor GI discomfort” messaging minimized potentially irreversible outcomes.
Who May Qualify for a GLP-1 Injury Claim?
You may qualify if:
- you took a GLP-1 medication
- you later developed a serious complication
- your condition required medical intervention
- you experienced long-term or ongoing damage
- your symptoms impaired work, nutrition, or quality of life
Most claim screens focus on patients diagnosed with:
- gastroparesis
- intestinal obstruction
- pancreatitis
- kidney injury or failure
- gallbladder disease or removal
- severe dehydration requiring hospital care
➡️ Check Eligibility:
File a Claim
Eligibility Criteria
Types of Compensation
Depending on case circumstances, compensation may cover:
- medical costs and hospitalization
- long-term treatment or surgery
- feeding support
- dialysis
- medication and testing
- lost income or reduced earning ability
- disability or long-term impairment
- pain, suffering, and quality-of-life loss
What Information Is Reviewed During a Case Evaluation
Case review teams commonly examine:
- medical diagnosis
- treatment records
- timing of symptoms
- hospital visits
- test results (scans, motility studies, kidney labs)
- surgical records
- drug prescribing history
Injuries That Often Strengthen Claims
In legal reviews, the strongest cases usually include at least one of these:
- diagnosed gastroparesis
- confirmed pancreatitis
- measurable kidney function decline
- gallbladder surgery
- intestinal obstruction
- months of vomiting or dehydration
- recurrent hospital admissions
- documented long-term impairment
How the Claims Process Works
Typical steps include:
- Initial injury review
- Medical documentation
- Eligibility evaluation
- Case assignment to legal counsel
- Evidence and record analysis
- Possible filing within applicable deadlines
- Negotiation or litigation
➡️ Process details: Legal Process
➡️ Filing deadlines: Statute of Limitations
Current Litigation Environment
Claims may proceed through:
- individual lawsuits
- mass-tort coordinated actions
- multidistrict litigation (MDL)
- ongoing investigations
The legal landscape continues evolving as more reports surface and studies examine long-term risk patterns.
➡️ Status updates: Current Litigation Status
Support, FAQs & Research Links
- GLP-1 Lawsuit FAQ
- Medical Research Links
- FDA Adverse Event Data
- Safety Alerts & Regulatory Changes
Ready to See if You Qualify?
If you developed a serious motor, pancreatic, kidney, or gallbladder injury after using a GLP-1 drug, you may be eligible for compensation.
➡️ Start here:
Check Eligibility & File a Claim
➡️ Review medical criteria:
Eligibility Requirements